Lessons from withdrawn accelerated approvals in oncology
George Mellgard(Memorial Sloan Kettering Cancer Center), Susan E. Bates(The Nature Conservancy), Tito Fojo(James J. Peters VA Medical Center)
Cited by 11
Related Papers
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
|Cellular and Molecular Life Sciences|2001|685
Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity
|JAMA Otolaryngology–Head & Neck Surgery|2014|301
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
|Drug Metabolism and Disposition|2010|216